previous
shown
primarili
respons
antivir
action
interferon
ifn
alphabeta
parainfluenza
viru
type
select
inhibit
translat
mrna
report
mump
viru
muv
sensit
nonrubulaviru
member
paramyxovirida
sendai
viru
sev
canin
distemp
viru
cdv
resist
sensit
rescu
coinfect
viru
demonstr
specif
inhibit
antivir
activ
inhibit
mrna
regul
cisact
element
develop
vitro
translat
system
use
purifi
human
investig
mechan
action
translat
muv
mrna
directli
inhibit
translat
sev
cdv
mrna
use
purifi
human
mrnacap
enzym
show
biochem
effici
inhibit
depend
upon
guanosin
nucleosid
cap
need
methyl
sensit
partli
abrog
methyl
cap
ribos
intriguingli
mrna
contrast
np
mrna
remain
sensit
inhibit
follow
vitro
methyl
suggest
structur
featur
mrna
may
influenc
sensit
thu
surprisingli
viral
polymeras
activ
rubulavirus
protect
virus
inhibit
possibl
biolog
consequ
discuss
citat
young
df
andrejeva
j
li
x
inestavaquera
f
dong
c
cowl
vh
goodbourn
randal
human
inhibit
mrna
translat
rubulavirus
member
paramyxovirida
famili
j
virol
paramyxovirus
caus
wide
varieti
diseas
yet
gene
encod
structur
protein
protein
involv
replic
cycl
thu
amount
genet
inform
determin
type
diseas
paramyxovirus
caus
rel
small
one
factor
influenc
diseas
outcom
interact
innat
host
cell
defens
includ
interferon
ifn
system
show
differ
paramyxovirus
interact
distinct
way
cell
preexist
ifninduc
antivir
state
strikingli
rubulavirus
test
sensit
antivir
action
paramyxovirus
test
resist
develop
novel
vitro
biochem
assay
investig
mechan
action
demonstr
mrna
rubulavirus
directli
inhibit
least
partial
mrna
correctli
methyl
p
aramyxovirus
larg
group
negativesens
singlestrand
rna
virus
caus
wide
varieti
anim
human
diseas
paramyxovirida
famili
divid
two
subfamili
paramyxovirina
pneumovirina
subfamili
paramyxovirina
subdivid
number
genera
includ
morbilliviru
eg
measl
viru
mev
canin
distemp
viru
cdv
respiroviru
eg
sendai
viru
sev
parainfluenza
viru
type
rubulaviru
eg
mump
viru
muv
paramyxovirus
envelop
virus
viral
glycoprotein
protrud
outer
surfac
envelop
function
attach
virus
target
cell
inner
surfac
envelop
matrix
protein
requir
structur
integr
virion
envelop
surround
helic
nucleocapsid
nucleocapsid
protein
np
encapsid
genom
antigenom
rna
associ
nucleocapsid
viral
encod
polymeras
complex
viral
polymeras
transcrib
replic
viral
genom
viral
mrna
cap
polyadenyl
viral
polymeras
review
molecular
biolog
paramyxovirus
see
refer
despit
limit
genet
inform
major
paramyxovirus
encod
small
multifunct
accessori
protein
function
aid
viru
multipl
block
cellular
antivir
defens
mechan
typic
protein
block
product
signal
respons
interferon
ifn
review
see
refer
significantli
mechan
action
multifunct
ifn
antagonist
differ
one
viru
anoth
undoubtedli
properti
gener
manner
paramyxovirus
interact
ifn
system
innat
defens
mechan
like
major
factor
determin
type
diseas
viru
caus
ifn
respons
extrem
power
antivir
defens
system
unless
counteract
virus
limit
replic
degre
caus
diseas
effici
transmit
suscept
host
infect
cell
detect
presenc
virus
due
product
virus
molecul
molecular
signatur
pathogenassoci
molecular
pattern
pamp
doublestrand
rna
dsrna
activ
ifn
induct
cascad
result
secret
infect
cell
releas
ifn
induc
antivir
state
neighbor
uninfect
cell
upregul
express
hundr
interferonstimul
gene
isg
mani
direct
indirect
antivir
activ
paramyxovirus
counteract
ifn
respons
produc
protein
block
ifn
induct
andor
ifn
signal
varieti
mechan
furthermor
tightli
control
viral
transcript
replic
therebi
limit
product
pamp
may
activ
ifn
respons
inde
probabl
mistak
virus
make
transcript
replic
product
copybackdefect
interf
particl
activ
ifn
respons
review
refer
nevertheless
abil
paramyxovirus
block
ifn
respons
tissu
cultur
cell
vivo
absolut
produc
furthermor
also
induc
antivir
state
cell
also
produc
activ
subset
lymphocyt
therefor
inevit
virus
infect
cell
preexist
ifninduc
antivir
state
potenti
limit
speed
viru
replic
spread
although
ifn
induc
hundr
isg
sever
isg
direct
antivir
activ
shown
specif
famili
group
relat
virus
regard
paramyxovirida
famili
previous
shown
refer
select
inhibit
translat
primari
effector
ifninduc
antivir
state
limit
replic
rubulaviru
pretreat
cell
inhibit
protein
synthesi
cellular
protein
synthesi
select
inhibit
translat
mrna
affect
cellular
mrna
mammalian
mrna
methyl
guanosin
gpppn
term
cap
end
recruit
factor
involv
rna
process
translat
initi
first
second
nucleosid
mammalian
mrna
also
methyl
hydroxyl
group
ribos
ring
gener
cap
cap
respect
cap
cap
requir
effici
mrna
translat
inhibit
translat
mrna
lack
cap
also
bind
uncap
rna
characterist
end
genom
antigenom
rna
rna
virus
well
viral
transcript
review
mechan
action
ifit
famili
protein
see
refer
howev
recent
evid
suggest
differ
mechan
action
murin
human
paralog
protein
murin
inhibit
translat
mrna
lack
cap
propos
human
recogn
asyetundefin
structur
near
cap
possibl
mrna
sequenc
may
help
defin
specif
inhibit
human
rnacap
activ
viral
rna
polymeras
often
includ
modifi
cap
thu
avoid
inhibit
b
evidenc
sensit
viru
mutant
lack
activ
review
see
refer
cap
methyl
viral
rna
also
import
modif
prevent
activ
rigi
therebi
reduc
amount
ifn
produc
viral
infect
cell
review
see
refer
examin
abil
inhibit
translat
varieti
paramyxoviru
mrna
thu
replic
virus
show
rubulavirus
test
sensit
nonrubulaviru
member
paramyxovirida
test
insensit
lack
omethyl
rubulaviru
mrna
least
partial
respons
inhibit
possibl
biolog
consequ
differ
sensit
paramyxovirus
discuss
cell
virus
antibodi
interferon
cell
deriv
grown
monolay
tissu
cultur
flask
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
appropri
cell
treat
human
recombin
interferon
intron
merck
sharp
dohm
unitsml
virus
use
studi
strain
colindal
strain
washington
js
recombin
js
virus
formerli
known
strain
cpi
cpi
muv
ender
respiratori
syncyti
viru
rsv
sendai
viru
strain
cantel
free
defect
interf
particl
canin
distemp
viru
strain
mill
hill
plaqu
assay
perform
standard
method
sixwel
dish
includ
avicel
fmc
biopolym
overlay
medium
plaqu
visual
immunostain
use
pool
monoclon
antibodi
polyclon
antisera
specif
differ
virus
describ
previous
togeth
alkalin
phosphataseconjug
secondari
antibodi
use
sigmafast
bcip
nbt
substrat
prepar
l
methioninelabel
totalcel
extract
sdspage
infect
uninfect
cell
pretreat
ifn
h
prior
infect
metabol
label
h
l
methionin
cimmol
mp
biomed
usa
h
postinfect
pi
label
cell
lyse
disrupt
buffer
sonic
heat
min
analyz
gel
electrophoresi
sdspage
gel
fix
stain
dri
resolv
band
visual
phosphorimag
analysi
appropri
amount
cell
equival
run
page
furthermor
amount
protein
sampl
monitor
stain
polyacrylamid
gel
pag
coomassi
brilliant
blue
immunofluoresc
cell
stain
immunofluoresc
grown
coverslip
scientif
laboratori
suppli
unit
kingdom
cell
stain
specif
monoclon
antibodi
mab
describ
detail
elsewher
briefli
monolay
fix
sucros
phosphatebuff
salin
pb
min
permeabil
nonidet
sucros
pb
min
wash
three
time
pb
contain
calf
serum
cell
detect
indirect
immunofluoresc
use
secondari
goat
antimous
ig
texa
redconjug
antibodi
catalog
number
abcam
primari
antibodi
stain
immunofluoresc
monolay
cell
examin
nikon
microphotfxa
immunofluoresc
microscop
rna
select
vitro
translat
rna
vitro
translat
isol
sediment
cscl
gradient
modifi
method
describ
leppert
et
al
confluent
monolay
infect
cell
grown
flask
resuspend
icecold
lysi
buffer
mm
nacl
mm
trishcl
ph
proteas
inhibitor
cocktail
complet
mini
edtafre
tablet
per
ml
buffer
roch
cell
per
ml
left
ice
min
prior
vortex
min
nuclei
remov
centrifug
twice
g
min
supernat
cytoplasm
extract
collect
made
mm
edta
layer
onto
wtwt
cscl
mm
trishcl
ph
mm
edta
follow
centrifug
g
h
nake
rna
includ
mrna
form
pellet
bottom
gradient
viral
genom
antigenom
rna
remain
complex
nucleoprotein
enter
cscl
cushion
supernat
discard
pellet
resuspend
rnasefre
water
adjust
gl
select
rna
translat
vitro
rabbit
reticulocyt
lysat
kit
promega
presenc
methioninecystein
easytag
express
protein
label
mix
perkinelm
use
modif
manufactur
instruct
methioninecysteinefre
medium
sigma
use
provid
amino
acid
l
per
l
reaction
mixtur
cap
methyl
mrna
human
rna
guanylyltransferas
rngtt
rna
methyltransferas
rnmt
cap
methyltransferas
synthes
purifi
accord
method
gonatopoulospournatzi
et
al
describ
studi
enzym
verifi
activ
vitro
reaction
follow
thinlay
chromatographi
cap
methyl
reaction
carri
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
dithiothreitol
dtt
buffer
follow
l
buffer
l
rngtt
mgml
l
rnmt
mgml
mgml
l
sam
mm
l
gtp
mm
l
rnasin
l
rna
gl
reaction
mixtur
made
l
h
includ
experi
rngtt
rnmt
omit
incub
h
clone
purif
amplifi
primer
plasmid
restrict
ncoi
xhoi
ligat
modifi
maltos
bind
protein
mpb
replac
sumo
sali
mutlipl
clone
site
mc
replac
xhoi
primer
follow
ccgccatggctacaaatggtgatgatcatcagg
gcgcctcgagctaaggaccttgtctcacagagtt
fusion
protein
hissumo
tev
express
escherichia
coli
strain
rosetta
liter
lbampicillinchloramphenicol
lb
ampcm
iptg
mm
ad
optic
densiti
od
reach
express
carri
overnight
purif
carri
routin
protocol
histag
protein
bind
buffer
contain
mm
trishcl
ph
nacl
mm
imidazol
wash
buffer
contain
mm
imidazol
protein
elut
mm
imidazol
remov
nonspecif
bound
rna
column
wash
volum
na
hpo
nacl
ph
desalt
gf
buffer
mm
trishcl
ph
mm
nacl
glycerol
fusion
cleav
tobacco
etch
viru
tev
proteas
room
temperatur
overnight
gel
filtrat
carri
pass
ni
bead
addit
mm
dtt
peak
collect
concentr
despit
fact
paramyxovirus
encod
ifn
antagonist
inhibit
ifn
product
signal
abil
block
ifn
respons
absolut
thu
form
larger
plaqu
ifnincompet
cell
ifncompet
cell
fig
show
viru
replic
spread
ifn
produc
slow
spread
virus
see
fig
experi
shown
fig
use
naiv
cell
naiv
cell
produc
respond
ifn
respons
viru
infect
cell
respond
exogen
ifn
produc
ifn
constitut
express
npro
bovin
viral
diarrhea
viru
bvdv
target
degrad
furthermor
degrad
cell
upregul
express
ifnindepend
manner
direct
respons
viru
infect
cell
produc
respond
ifn
express
endogen
respons
ifn
viral
infect
inhibit
due
constitut
express
small
hairpin
rna
shrna
previous
show
major
cellular
protein
respons
ifn
sensit
rubulaviru
investig
role
abil
ifn
induc
antivir
state
paramyxovirus
initi
test
abil
form
plaqu
cell
three
virus
induc
ifn
cell
plaqu
develop
observ
induct
mxa
uninfect
cell
surround
plaqu
fig
previous
observ
form
bigger
plaqu
cell
cell
plaqu
larg
cell
fig
also
produc
slightli
larger
plaqu
cell
plaqu
cell
obvious
bigger
note
center
midto
larges
plaqu
fallen
monolay
produc
similarli
size
plaqu
cell
slightli
larger
plaqu
cell
result
also
support
previou
conclus
cell
primari
isg
effector
rubulaviru
also
sensit
howev
knock
mark
effect
plaqu
size
indic
like
addit
isg
play
import
role
ifnmedi
inhibit
contrast
washington
strain
produc
similarli
size
plaqu
cell
slightli
larger
plaqu
cell
suggest
ifn
respons
capabl
slow
spread
degre
activ
dramat
howev
experi
js
strain
show
sensit
antivir
effect
ifn
js
sensit
data
shown
next
compar
synthesi
viral
protein
cell
infect
pretreat
ifn
prior
infect
cell
infect
high
multipl
infect
moi
pfucel
rel
level
np
synthesi
visual
radioact
label
cell
h
methionin
h
pi
fig
pretreat
cell
ifn
assay
reduc
express
np
bare
detect
level
howev
ifn
pretreat
discern
effect
express
np
protein
express
host
cell
protein
strikingli
express
np
larg
rescu
ifnpretr
cell
demonstr
play
major
role
inhibit
protein
synthesi
observ
cell
pretreat
ifn
figur
exemplar
mani
similar
experi
perform
differ
condit
time
cours
moi
etc
show
result
name
inhibit
demonstr
sensit
resist
test
sensit
member
paramyxovirida
famili
name
mump
viru
muv
strain
ender
sendai
viru
sev
canin
distemp
viru
cdv
set
experi
similar
illustr
fig
cell
pretreat
ifn
prior
infect
high
moi
virus
rel
level
np
synthesi
visual
radioact
label
cell
h
methionin
h
pi
fig
experi
clearli
demonstr
observ
pretreat
cell
ifn
inhibit
muv
strain
ender
protein
synthesi
knock
express
could
larg
restor
muv
protein
synthesi
contrast
observ
although
pretreat
cell
ifn
slightli
reduc
express
sev
cdv
protein
synthesi
increas
sev
cdv
protein
synthesi
observ
compar
cell
pretreat
ifn
result
therefor
show
muv
ender
sensit
sev
cdv
weak
inhibit
sev
cdv
protein
synthesi
observ
cell
pretreat
ifn
presum
due
action
isg
induc
ifn
muv
sensit
form
pinpoint
plaqu
cell
day
pi
data
shown
strongli
suggest
host
cell
restrict
innat
intracellular
defens
mechan
muv
replic
cell
sinc
experi
use
attenu
ender
strain
muv
test
whether
attenu
may
link
sensit
test
wildtyp
wt
isol
sensit
time
also
test
sensit
anoth
strain
term
cpi
fig
muvlo
sensit
muv
ender
demonstr
attenu
link
differ
rel
sensit
similarli
cpi
also
sensit
inhibit
sensit
rescu
coinfect
viru
result
clear
replic
nonrubulavirus
sev
cdv
inhibit
investig
whether
replic
could
rescu
coinfect
viru
mix
infect
undertaken
avoid
possibl
synergist
effect
dismantl
ifninduc
antivir
state
cpi
strain
use
experi
due
mutat
v
protein
block
ifn
signal
cell
pretreat
ifn
h
prior
highmoi
pfucel
infect
mixtur
two
virus
fig
express
np
protein
resist
ifn
cell
infect
alon
coinfect
contrast
express
np
resist
ifn
cell
express
inhibit
cell
even
cell
coinfect
immunofluoresc
undertaken
ensur
experi
exclus
one
viru
fig
c
result
confirm
coinfect
rescu
sensit
strongli
suggest
specif
inhibit
antivir
activ
inhibit
np
express
regul
cisact
element
differenti
inhibit
translat
mrna
differ
paramyxovirus
purifi
data
show
ifn
sensit
rubulavirus
least
part
due
action
sinc
cellular
protein
shown
inhibit
translat
templatespecif
manner
develop
vitro
translat
system
studi
abil
human
select
inhibit
translat
rubulaviru
mrna
gene
encod
human
clone
sumo
fusion
protein
express
escherichia
coli
recombin
protein
purifi
fig
determin
whether
recombin
abl
select
inhibit
mrna
vitro
translat
mrna
isol
mockand
cell
carri
presenc
absenc
differ
concentr
fig
c
absenc
express
np
protein
lesser
extent
protein
clearli
visual
background
vitrotransl
cellular
protein
fig
increas
concentr
obviou
effect
effici
translat
host
cell
protein
strike
contrast
purifi
select
inhibit
translat
np
protein
concentrationdepend
manner
establish
sensit
vitro
translat
mrna
inhibit
purifi
correl
biolog
sensit
next
test
abil
inhibit
translat
mrna
isol
cell
infect
paramyxovirus
fig
result
clearli
demonstr
translat
np
mrna
muvinfect
cell
inhibit
contrast
obviou
reduct
amount
np
synthes
increas
amount
ad
vitro
translat
reaction
mixtur
although
slight
appar
reduct
amount
sev
cdv
np
synthesi
sampl
ad
increas
inhibit
observ
increas
amount
ad
vitro
translat
reaction
mixtur
strongli
suggest
translat
sev
cdv
mrna
also
resist
inhibit
lack
methyl
cap
structur
muv
mrna
partial
respons
sensit
inhibit
previou
studi
shown
absenc
cap
mrna
render
sensit
inhibit
investig
whether
case
rubulaviru
mrna
develop
vitro
assay
purifi
human
mrnamodifi
enzym
use
progress
cap
add
differ
methyl
group
end
mrna
purifi
human
rna
guanylyltransferas
rngtt
rna
methyltransferas
rnmt
cap
methyltransferas
use
assay
rngtt
add
guanosin
rna
rnmt
add
methyl
group
g
guanin
ring
gener
g
cap
add
methyl
group
oh
posit
adjac
ribos
gener
cap
demonstr
function
system
first
test
vitro
translat
luciferas
mrna
group
rna
effici
translat
capindepend
manner
weakli
inhibit
fig
compar
lane
luciferas
mrna
cap
addit
rngtt
gener
gpppmrna
slight
decreas
amount
luciferas
made
fig
compar
lane
may
due
rngtt
destabil
block
translat
gpppmrna
absenc
n
methyl
howev
strikingli
translat
mrna
complet
inhibit
fig
lane
despit
cap
structur
lack
methyl
expect
addit
methyl
group
posit
guanin
ring
gener
gpppm
n
rnmt
increas
effici
translat
gpppluciferas
remain
complet
sensit
inhibit
fig
lane
addit
methyl
group
oh
group
adjac
ribos
gener
cap
affect
effici
mrna
translat
clearli
reduc
sensit
mrna
inhibit
fig
compar
lane
howev
note
experi
reason
unclear
unabl
complet
restor
full
translat
luciferas
mrna
presenc
increas
amount
length
incub
mrna
enzym
data
shown
investig
similar
modif
cap
rubulaviru
mrna
influenc
inhibit
initi
use
muv
mrna
parallel
set
experi
result
show
treatment
muv
mrna
rngtt
rnmt
increas
effici
vitro
translat
muv
np
mrna
sensit
inhibit
fig
lane
consist
viral
polymeras
ad
gpppcap
cap
end
viral
mrna
howev
surprisingli
sinc
rubulaviru
polymeras
conserv
mtase
domain
addit
methyl
group
group
adjac
ribos
cap
clearli
reduc
sensit
np
mrna
inhibit
fig
lane
expect
sensit
depend
addit
sadenosyl
methionin
sam
reaction
mixtur
fig
similarli
follow
methyl
mrna
vitro
translat
np
becam
complet
resist
inhibit
fig
strikingli
contrast
np
translat
mrna
remain
complet
sensit
inhibit
even
methyl
mrna
fig
e
basi
current
unknown
investig
past
decad
becom
clear
way
paramyxovirus
circumv
innat
immun
respons
includ
ifn
respons
differ
multifunct
natur
ifn
antagonist
like
influenc
type
diseas
caus
exampl
viral
ifn
antagonist
within
rubulaviru
genu
name
v
protein
well
interact
common
target
mda
also
uniqu
properti
v
protein
target
degrad
target
muv
target
within
respiroviru
morbilliviru
genera
combin
v
c
protein
counteract
innat
respons
differ
molecular
mechan
strikingli
although
encod
c
protein
encod
function
v
protein
despit
encod
power
ifn
antagonist
ifn
produc
viru
spread
tissu
cultur
cell
vivo
thu
undoubtedli
paramyxovirus
cours
infect
infect
cell
preexist
ifninduc
antivir
state
show
differ
paramyxovirus
interact
distinct
way
cell
preexist
ifninduc
antivir
state
suggest
may
influenc
type
diseas
caus
strikingli
contrast
sensit
rubulavirus
paramyxovirus
test
resist
strongli
suggest
might
distinguish
featur
rubulavirus
although
firmli
conclud
sensit
speci
paramyxovirus
need
test
even
within
rubulaviru
genu
appear
may
differ
member
interact
cell
ifninduc
antivir
state
cell
primarili
respons
ifninduc
antivir
state
induc
counter
howev
although
sensit
appear
isg
strong
activ
conclus
come
observ
slight
increas
size
plaqu
cell
compar
cell
obviou
observ
furthermor
plaqu
smaller
cell
cell
differ
mark
observ
muv
strain
ender
also
sensit
clearli
major
constraint
growth
muv
ender
human
cell
viru
grow
extrem
poorli
ifnincompet
human
cell
replic
high
titer
vero
cell
strike
rubulavirus
sensit
antivir
activ
human
data
indic
inhibit
rubulaviru
mrna
produc
cislink
manner
impli
restrict
associ
featur
uncap
mrna
encod
luciferas
synthes
polymeras
provid
control
promega
vitro
translat
kit
translat
vitro
rabbit
reticulocyt
lysat
absenc
presenc
purifi
lane
rngtt
use
add
guanin
cap
lane
rnmt
use
methyl
cap
posit
lane
gener
cap
use
methyl
adjac
ribos
oh
posit
gener
cap
modifi
mrna
vitro
translat
absenc
lane
presenc
lane
b
mrna
isol
muvinfect
cell
treat
parallel
condit
describ
panel
c
mrna
isol
either
muv
ender
infect
cell
vitro
translat
prior
lane
follow
lane
modif
presenc
absenc
lane
sam
mrna
also
translat
absenc
lane
presenc
lane
purifi
e
densitometri
trace
lane
panel
number
bottom
gel
indic
fraction
either
host
cell
protein
np
protein
made
vitro
translat
mix
presenc
purifi
compar
made
absenc
mrna
sequenc
structur
sinc
select
inhibit
translat
mrna
incorrectli
cap
methyl
oh
group
first
ribos
ie
cap
like
rubulavirus
structur
motif
cap
present
hidden
mrna
paramyxovirus
recogn
investig
use
purifi
human
enzym
modifi
cap
mrna
control
activ
enzym
use
uncap
mrna
encod
luciferas
luciferas
mrna
translat
capindepend
manner
vitro
use
rabbit
reticulocyt
lysat
translat
weakli
inhibit
purifi
addit
guanosin
nucleosid
cap
slightli
decreas
amount
luciferas
synthes
probabl
enzym
rngtt
destabil
mrna
addit
unmethyl
guanosin
nucleosid
end
mrna
significantli
increas
sensit
mrna
inhibit
furthermor
although
methyl
guanin
ring
posit
rnmt
increas
effici
translat
luciferas
mrna
appear
affect
sensit
inhibit
result
therefor
consist
observ
human
bind
low
affin
rna
avidli
cap
rna
lack
methyl
methyl
posit
guanin
ring
also
report
increas
affin
bind
howev
observ
gpppluciferas
inhibit
effici
suggest
methyl
group
play
central
role
inhibit
mrna
contrast
omethyl
first
ribos
gener
cap
partial
prevent
inhibit
translat
cap
mrna
howev
even
increas
amount
incub
time
unabl
complet
restor
full
translat
activ
luciferas
mrna
reason
unclear
suggest
structur
featur
exampl
methyl
penultim
ribos
gener
cap
sequenc
end
mrna
may
also
influenc
inhibit
suggest
daugherti
et
al
mrna
isol
sev
cdvinfect
cell
inhibit
neither
replic
virus
fig
contrast
omethyl
termin
ribos
muv
mrna
partial
allevi
inhibit
np
mrna
regard
previou
studi
suggest
mrna
omethyl
furthermor
never
observ
complet
inhibit
np
synthesi
vitro
suggest
least
proport
np
mrna
correctli
cap
howev
fact
treat
mrna
rescu
np
synthesi
presenc
suggest
signific
proport
mrna
also
fulli
methyl
also
potenti
signific
mrna
appear
sensit
np
mrna
inhibit
furthermor
translat
inhibit
mrna
rescu
treatment
differ
rel
sensit
np
mrna
clearli
warrant
investig
may
due
fact
viral
methyltransferas
differenti
methyl
viral
mrna
shown
vesicular
stomat
viru
vsv
recogn
untransl
region
utr
mrna
inhibit
influenc
addit
structur
featur
present
mrna
np
mrna
regard
latter
point
note
first
three
nucleotid
utr
np
differ
furthermor
nucleotid
downstream
cap
thought
bound
may
thu
modul
interact
secondari
rna
structur
eg
found
end
alphavirus
prevent
bind
rna
independ
cap
methyl
statu
virus
success
avoid
inhibit
encod
mtase
cap
snatch
appropri
cap
methyl
structur
cellular
mrna
capindepend
translat
coval
link
viral
protein
vpg
rna
secondari
structur
block
activ
review
refer
inde
work
viru
restrict
involv
primarili
investig
virus
mutat
mrna
cap
structur
nevertheless
result
show
viral
polymeras
rubulavirus
unlik
paramyxovirus
fulli
protect
viral
mrna
inhibit
human
regard
interest
although
rubulavirus
conserv
methyltransferas
domain
polymeras
alanin
instead
first
glycin
gxgxg
motif
present
methyltransferas
domain
paramyxovirus
mononegaviral
shown
affect
effici
cap
methyl
virus
includ
mononegaviral
appear
natur
resist
inhibit
therefor
intrigu
rubulavirus
evolv
mechan
ensur
mrna
correctli
cap
methyl
appropri
utr
resist
tempt
specul
unknown
biolog
advantag
sensit
exampl
may
help
rubulavirus
perhap
hepat
c
viru
also
sensit
establish
prolong
persist
infect
thu
follow
infect
cell
ifninduc
antivir
state
restrict
replic
condit
viru
genom
locat
cytoplasm
foci
previous
suggest
may
remain
hidden
intracellular
adapt
immun
respons
furthermor
viral
mrna
produc
cell
ifninduc
antivir
state
viral
protein
synthesi
larg
inhibit
thu
reduc
amount
protein
may
process
present
cytotox
lymphocyt
ctl
eventu
cell
howev
enough
viru
ifn
antagonist
v
protein
produc
brought
infect
viru
particl
target
proteasomemedi
degrad
cell
longer
abl
maintain
antivir
state
thu
facilit
viru
replic
whether
scenario
occur
vivo
consider
emphas
fulli
understand
molecular
pathogenesi
virus
necessari
understand
subtleti
virus
interact
ifn
system
host
cell
defens
mechan
